Evidence map›Paper›PMID 37207207›Full record

ArticleFrontiers in immunology2023

Elevated

Qianqian Cheng, Wei Wang, Jing Liu, Zhenyu Lv, Wenbin Ji, Jinhui Yu, Wenting Zhang, Yan Yang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Qianqian ChengDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Wei WangDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Jing LiuDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Zhenyu LvDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Wenbin JiDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Jinhui YuDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Wenting ZhangDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Yan YangDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
First Affiliated Hospital of Bengbu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Membrane palmitoylated proteins (MPPs) are engaged in various biological processes, such as cell adhesion and cell polarity. Dysregulated MPP members have different effects on hepatocellular carcinoma (HCC) development. However, the role of Method: HCC transcriptome and clinical data from different public databases were downloaded and analyzed, and the results were further validated by qRT-PCR, Western blotting and immunohistochemistry (IHC) using HCC cell lines and tissues. The association between Results: Conclusions: Elevated

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsMembrane ProteinsCardiovascular Physiological PhenomenaHumansImmune EvasionPrognosisTumor MicroenvironmentMembrane ProteinsMPP6 protein, humanangiogenesishepatocellular carcinomaimmune evasionMPP6prognosistreatment response

Identifiers

PMID37207207
PMCPMC10189050
OpenAlexW4367845243

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.